Heliogen Inc. (NYSE:HLGN) finished Friday with a subtraction of -$0.01 to close at $0.22, a downside of -6.84 percent. An average of 641,300 shares of common stock have been traded in the last five days. There was a fall of -$0.0422 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 627,805 shares traded, while the 50-day average volume stands at 1,683,396.
HLGN stock has decreased by -23.35% in the last month. The company shares reached their 1-month lowest point of $0.2111 on 08/09/23. With the stock rallying to its 52-week high on 01/18/23, shares of the company touched a low of $0.19 and a high of $3.02 in 52 weeks. It has reached a new high 3 times so far this year and lost -68.96% or -$0.4815 in price. In spite of this, the price is down -92.82% from the 52-week high.
Insider Transactions
HLGN stock investors should be aware that Heliogen Inc. (HLGN) stock had its last reported insider trading activity 51 days ago on Jun 22. In this transaction, the insider spent $167,972. Chief Executive Officer, Obiaya Christiana, disposed of 30,441 shares at a price of $0.23 on Jun 20. The insider now owns more than $7,117 worth of shares. Prior to that, Chief Commercial Officer Doyle Thomas P. went on to Sale 10,302 shares at $0.23 each on Jun 20. An amount of $2,409 was transacted.
Valuation Metrics
Heliogen Inc. (HLGN) stock’s beta is 2.10. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.53, the price-to-book (PB) ratio at 0.40.
Financial Health
The quick ratio of Heliogen Inc. for the three months ended March 30 was 2.80, and the current ratio was 2.90, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30. Heliogen Inc.’s EBITDA margin for the year ending March 30 is -1084.36%. Its gross profit as reported stood at -$33.78 million compared to revenue of $13.75 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Heliogen Inc.’s return on assets was -45.80%.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$21.68 million in the quarter, while revenues were grew 6.73%. The analyst consensus anticipated Heliogen Inc.’s latest quarter earnings to come in at -$0.15 per share, but it turned out to be -$0.09, a 40.00% surprise. For the quarter, EBITDA amounted to -$22.13 million. At the end of the quarter ending March 30, Heliogen Inc.’s stock balance sheet showed total liabilities of 65.6 million. Shareholders own equity worth $205.1 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Heliogen Inc. (HLGN) price momentum. RSI 9-day as of the close on 11 August was 30.82%, suggesting the stock is Neutral, with historical volatility in this time frame at 59.14%.
As of today, HLGN’s price is $0.2314 -16.30% or -$0.0422 from its 5-day moving average. HLGN is currently trading -19.74% lower than its 20-day SMA and +14.05% higher than its 100-day SMA. However, the stock’s current price level is -11.62% below the SMA50 and -88.41% below the SMA200.
The stochastic %K and %D were 15.60% and 14.55%, respectively, and the average true range (ATR) was 0.0223. With the 14-day stochastic at 7.16% and the average true range at 0.0232, the RSI (14) stands at 36.75%. The stock has reached -0.0174 on the 9-day MACD Oscillator while the 14-day reading was at -0.0247.
Analyst Ratings
Citigroup launched coverage on Heliogen Inc. (NYSE: HLGN) in its analyst report released on January 25, 2022. The firm assigned the stock a Neutral rating. The consensus rating for Heliogen Inc. (HLGN) among analysts is Overweight. According to current brokerage recommendations, 0 brokerage firms advise that investors sell HLGN, while 2 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is HLGN’s price target for the next 12 months?
Analysts predict a range of price targets between $0.25 and $3.00, with a median target of $0.65. Taking a look at these predictions, the average price target given by analysts for Heliogen Inc. (HLGN) stock is $1.30.
